Andres Emanuelli, MD: Analysis of the Port Delivery System in the Phase 3 Pavilion Trial
At ARVO 2023, Emanuelli discusses the primary analysis results of the phase 3 Pavilion trial evaluating the PDS with ranibizumab in patients with diabetic retinopathy without center-involved diabetic macular edema.